186: Is TURP Still the Gold Standard for BPH? John Lin, MD Explains

Is TURP (Transurethral Resection of the Prostate) still the gold standard for treating benign prostatic hyperplasia (BPH) in the era of lasers, implants, and minimally invasive therapies? In this in-depth educational discussion for UroNurse, renowned urologist John Lin, MD, shares his expert perspective on TURP—a procedure he remains deeply passionate about and has performed over 100 times annually for many years. Dr. Lin breaks down why TURP has stood the test of time, where it still excels, and how it compares to newer BPH treatment options. Hosted by Vic Senese, RN, BSN, FAUNA, this episode is designed for urology nurses, advanced practice providers, medical professionals, and informed patients seeking clarity amid the growing number of prostate treatment choices. 🔍 Topics Covered Include: Why TURP became the gold standard for BPH Long-term outcomes and durability of TURP TURP vs laser prostate surgery (HoLEP, GreenLight, etc.) Patient selection: who benefits most from TURP today Complications, recovery, and nursing considerations How surgeon experience impacts TURP outcomes Is TURP being replaced—or refined? With decades of clinical data and real-world experience, Dr. Lin offers a grounded, evidence-based discussion that cuts through the hype and focuses on what truly works for patients. If you’re navigating prostate treatment decisions or caring for patients with lower urinary tract symptoms, this conversation provides practical insight you won’t want to miss. 👉 Subscribe to the UroNurse channel for more expert-led urology education:    / @uronurse1   *The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.